Health-related quality of life (HRQoL) for pembrolizumab or placebo plus carboplatin and paclitaxel or nab-paclitaxel in patients with metastatic squamous NSCLC: Data from KEYNOTE-407

Mazieres, J.Kowalski, D.Luft, A.Vicente, D.Tafreshi, A.Gumus, M.Laktionov, K.2024-06-122024-06-1220180923-75341569-8041https://hdl.handle.net/20.500.14551/2679743rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANY[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Health-related quality of life (HRQoL) for pembrolizumab or placebo plus carboplatin and paclitaxel or nab-paclitaxel in patients with metastatic squamous NSCLC: Data from KEYNOTE-407Conference Object29Q1WOS:000459277305011